{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:23:50Z","timestamp":1790630630990,"version":"4.1.0"},"reference-count":66,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mycophenolic acid was first discovered in 1913 and first used clinically in the 1970s as an immunosuppressant to prevent organ transplantation rejection. It was later used in the treatment of psoriasis. However due to its side\u2010effect profile and fears over its carcinogenic potential it was abandoned. From the late 1990s a prodrug, mycophenolate mofetil (<jats:styled-content style=\"fixed-case\">MMF<\/jats:styled-content>), was developed and more recently, enteric\u2010coated mycophenolate sodium (<jats:styled-content style=\"fixed-case\">EC\u2010MPS<\/jats:styled-content>), both of which have gained increasing use in the field of dermatology for a variety of skin conditions. This review discusses the pharmacology, mechanisms of action, side\u2010effects and current clinical applications in dermatology of <jats:styled-content style=\"fixed-case\">MMF<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">EC\u2010MPS<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/ajd.12259","type":"journal-article","created":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T03:05:48Z","timestamp":1419995148000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mycophenolic acid in dermatology a century after its discovery"],"prefix":"10.1111","volume":"56","author":[{"given":"Sarah J","family":"Strathie Page","sequence":"first","affiliation":[{"name":"Royal Perth Hospital  Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare P","family":"Tait","sequence":"additional","affiliation":[{"name":"Royal Perth Hospital  Perth Western Australia Australia"},{"name":"Department of Dermatology Royal Perth Hospital  Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"e_1_2_13_2_1","first-page":"1","article-title":"Contribution to the study of maize deterioration; biochemical and toxicological investigations of Penicillium puberulum and Penicillium stoloniferum","volume":"270","author":"Alsberg CL","year":"1913","journal-title":"Bur. Plant Ind. Bull."},{"key":"e_1_2_13_3_1","first-page":"1","article-title":"Mycophenolate mofetil: a dermatologic perspective","volume":"10","author":"Mydlarski PR","year":"2005","journal-title":"Skin Therapy Lett."},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj0390398"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/am.18.1.14-20.1969"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310016826"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(55)90347-7"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2007.00136.x"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.1997.046"},{"key":"e_1_2_13_10_1","first-page":"1414","volume-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","author":"Krensky A","year":"2006"},{"key":"e_1_2_13_11_1","unstructured":"Roche.CellCept capsule data sheet. Roche;2012. Available from URL:http:\/\/www.medsafe.govt.nz\/profs\/Datasheet\/c\/CellCeptcapsuspinf.pdf. (Accessed 20 Sep 2013.)"},{"key":"e_1_2_13_12_1","unstructured":"Novartis.Myfortic (mycophenolic acid) delayed\u2010release tablets.2011. Available from URL:http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/ucm310868.htm. (Accessed 21 Nov 2013.)"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92534-1"},{"key":"e_1_2_13_14_1","unstructured":"Australian Government Department of Health.Pharmaceutical benefits scheme. Australian Government Department of Health;2014. Available from URL:http:\/\/www.pbs.gov.au\/medicine\/item\/1836P. (Accessed 24 Sep 2013.)"},{"key":"e_1_2_13_15_1","unstructured":"Ngan Vanessa.Mycophenolate mofetil. DermNet NZ;2014. Available from URL:http:\/\/dermnetnz.org\/treatments\/mycophenolate.html. (Accessed 2 October 2014.)"},{"key":"e_1_2_13_16_1","unstructured":"Pharmaceutical Management Agency.Online pharmaceutical schedule: azathioprine. Ministry of Health;2014. Available from URL:http:\/\/www.pharmac.govt.nz\/patients\/PharmaceuticalSchedule\/Schedule?osq=azathio&search_path=http%3A%2F%2Fwww.pharmac.govt.nz%2Fpatients%2FPharmaceuticalSchedule%2FSchedule. (Accessed 2 Oct 2014.)"},{"key":"e_1_2_13_17_1","unstructured":"Pharmaceutical Management Agency.Online pharmaceutical schedule: ciclosporin. Ministry of Health;2014. Available from URL:http:\/\/www.pharmac.govt.nz\/healthpros\/Schedule?osq=Ciclosporin. (Accessed 9 October 2014)."},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12042"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.08.049"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb17144.x"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)63607-1"},{"key":"e_1_2_13_22_1","first-page":"18","article-title":"The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room","volume":"4","author":"Park H","year":"2011","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00337.x"},{"key":"e_1_2_13_24_1","first-page":"159","article-title":"Mycophenolate mofetil; a review of indications and use in a large tertiary hospital","volume":"4","author":"Geevasinga N","year":"2005","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(01)02377-6"},{"key":"e_1_2_13_26_1","unstructured":"National Health Service.Shared care guideline: mycophenolate mofetil. British Association of Dermatologists;2013. Available from URL:http:\/\/www.bad.org.uk\/for\u2010the\u2010public\/patient\u2010information\u2010leaflets\/mycophenolate\u2010mofetil?q=Mycophenolatemofetil#.VC_L0vaKDUM. (Accessed 2 October 2014)"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.860419"},{"key":"e_1_2_13_28_1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.1977.01640090051004","article-title":"Mycophenolic acid for psoriasis","volume":"113","author":"Lynch WS","year":"1977","journal-title":"Arch. Dermatol."},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel216a"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12610346"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(79)80097-3"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70285-0"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03667.x"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00870.x"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000226134"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04246.x"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.12.1536"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.01.007"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.09.026"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.08.002"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.04.027"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.039"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.91"},{"key":"e_1_2_13_44_1","first-page":"210","article-title":"Mycophenolate mofetil as a first\u2010line steroid\u2010sparing agent in the treatment of pemphigus vulgaris","volume":"12","author":"Vyas N","year":"2013","journal-title":"J. Drugs Dermatol."},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03914.x"},{"key":"e_1_2_13_46_1","first-page":"356","article-title":"Mycophenolate mofetil for the treatment of chronic dermatitis: an open\u2010label study of 16 patients","volume":"9","author":"Jackson JM","year":"2010","journal-title":"J. Drugs Dermatol."},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.027"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120032"},{"key":"e_1_2_13_49_1","doi-asserted-by":"crossref","DOI":"10.5070\/D38Z97B9JB","article-title":"Treatment of lichen planopilaris with mycophenolate mofetil","volume":"10","author":"Tursen U","year":"2004","journal-title":"Dermatol. Online J."},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)02111-X"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.05.018"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12141"},{"key":"e_1_2_13_53_1","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases","volume":"27","author":"Gelber AC","year":"2000","journal-title":"J. Rheumatol."},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051674"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.1.65"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20269"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740701607042"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.08.011"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07826.x"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63571-4"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.57"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410020154"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.028"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00606.x"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.03.027"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12072"},{"key":"e_1_2_13_67_1","unstructured":"NHMRC.A guide to the development implementation and evaluation of clinical practice guidelines. NHMRC;1999. Available from URL:http:\/\/www.nhmrc.gov.au\/_files_nhmrc\/publications\/attachments\/cp30.pdf. (Accessed 2 Jan 2014.)"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajd.12259","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.12259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:10:56Z","timestamp":1695471056000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.12259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/ajd.12259"],"URL":"https:\/\/doi.org\/10.1111\/ajd.12259","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]},"assertion":[{"value":"2014-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}